Expression and clinical significance of cyclin kinase subunit 2 in colorectal cancer

Yu,Minhao; Zhong,Ming; Qiao,Zhongdong

doi:10.3892/ol.2013.1456

Expression and clinical significance of cyclin kinase subunit 2 in colorectal cancer

Authors:
- Minhao Yu
- Ming Zhong
- Zhongdong Qiao
View Affiliations

Affiliations: Department of Surgery, Renji Hospital, Shanghai Jiaotong University, Shanghai 200127, P.R. China
Published online on: July 11, 2013 https://doi.org/10.3892/ol.2013.1456
Pages: 777-780

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The overexpression of cyclin kinase subunit 2 (CKS2) is tightly correlated with tumor aggressiveness and prognosis in various malignancies, including gastric, breast, liver and prostate cancer. However, whether CKS2 is upregulated in colorectal cancer (CRC) remains unknown. The aim of the present study was to analyze CKS2 expression levels in CRC, and to determine the clinical diagnostic and prognostic values of CKS2 overexpression in CRC patients. CKS2 expression was analyzed at the mRNA and protein levels by quantitative (q)PCR and western blot analysis. CKS2 expression was significantly upregulated in CRC compared with the adjacent non‑cancer and normal colorectal tissues. The overexpression of CKS2 was correlated with poor differentiation and the pathological stage. In addition, CKS2 overexpression was correlated with aggressive tumor progression in CRC, which indicated that CKS2 may serve as a good CRC biomarker.

View Figures

View References

1	Hanahan D and Weinberg RA: The hallmarks of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
2	Edge SB: AJCC Staging Manual. 7th edition. Springer; New York, NY: 2010
3	Le Voyer TE, Sigurdson ER, Hanlon AL, et al: Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survery of intergroup trial INT-0089. J Clin Oncol. 21:2912–2919. 2003.
4	Siena S, Sartore-Bianchi A, Di Nicolantonio F, et al: Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst. 101:1308–1324. 2009. View Article : Google Scholar : PubMed/NCBI
5	Chu DZ, Erickson CA, Russell MP, et al: Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Serum levels before and after resection and before recurrence. Arch Surg. 126:314–316. 1991. View Article : Google Scholar : PubMed/NCBI
6	Williams RT, Wu L, Carbonaro-Hall DA, et al: Identification of a novel cyclin-like protein in human tumor cells. J Biol Chem. 268:8871–8880. 1993.PubMed/NCBI
7	Slotky M, Shapira M, Ben-Izhak O, et al: The expression of the ubiquitin ligase subunit Cks1 in human breast cancer. Breast Cancer Res. 7:R737–R744. 2005. View Article : Google Scholar : PubMed/NCBI
8	Shapira M, Ben-Izhak O, Linn S, et al: The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma. Cancer. 103:1336–1346. 2005. View Article : Google Scholar : PubMed/NCBI
9	Lan Y, Zhang Y, Wang J, et al: Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death. Int J Cancer. 123:543–551. 2008. View Article : Google Scholar : PubMed/NCBI
10	Liu Z, Fu Q, Lv J, Wang F and Ding K: Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study. J Exp Clin Cancer Res. 27:512008. View Article : Google Scholar : PubMed/NCBI
11	Kawakami K, Enokida H, Tachiwada T, et al: Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling. Oncol Rep. 16:521–531. 2006.PubMed/NCBI
12	Kang MA, Kim JT, Kim JH, et al: Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer. J Cancer Res Clin Oncol. 135:761–769. 2009. View Article : Google Scholar : PubMed/NCBI
13	Shen DY, Fang ZX, You P, et al: Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma. Liver Int. 30:119–125. 2009. View Article : Google Scholar : PubMed/NCBI
14	Alhasan SA, Ensley JF, Sarkar FH, et al: Genistein induced molecular changes in a squamous cell carcinoma of the head and neck cell line. Int J Oncol. 16:333–338. 2000.PubMed/NCBI
15	Hansel DE, Dhara S, Huang RC, et al: CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target. Am J Surg Pathol. 29:390–399. 2005. View Article : Google Scholar
16	Martinsson-Ahlzén HS, Liberal V, Grünenfelder B, et al: Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells. Mol Cell Biol. 28:5698–5709. 2008.